The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer.
The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer. Transl Androl Urol. 2019 Dec; 8(Suppl 5):S533-S537.